From Community-Based to Community-Led Trial?

Community-Based Clinical Trial (CBCT) refers to a clinical trial conducted primarily through primary-care physicians, community health centers, and local outpatient facilities rather than academic research centers. CBCTs are held to the same standards as clinical trials at academic centers, including Institutional Review Board (IRB) approval. CBCTs have similar designs as clinical trials at academic research centers (for example, the trial may be desinged as a randomized, double blind, placebo-controlled study).

Theranium is at the forefront of advancing the community-based clinical trial model towards a more community-led approach, aiming to further enhance the inclusivity and relevance of clinical research. By actively involving local stakeholders, including patients, community leaders, and healthcare providers in the design and implementation phases of trials, Theranium ensures that the research is not only conducted in the community but is also shaped by the community's needs and priorities. This approach empowers local participants to have a voice in the research process, making the trials more responsive to real-world conditions and increasing the likelihood of obtaining results that are applicable and beneficial to the community.

In addition, Theranium is pioneering the integration of digital tools and platforms to facilitate community-led trials. By leveraging telemedicine, mobile health applications, and data collection technologies, Theranium enhances participant engagement and streamlines trial management. These innovations allow for more flexible and efficient data collection, real-time monitoring, and communication between researchers and participants. This digital transformation not only improves the efficiency and accessibility of clinical trials but also helps build stronger community connections, as participants can engage with the research process from their own homes, thereby reducing barriers and increasing overall participation rates.